Under construction – not a live service
Sign in
Taking peopleNo phase

SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 65 and 100 years old?

Source: NCT07449442, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Poznan University of Medical Sciences
Trial code
NCT07449442
Record updated
5 November 2026
Original description
This randomized controlled trial evaluates the effect of ultrasound-guided iPACK block with Adductor Canal Block (ACB) on the Systemic Immune-Inflammation Index (SII) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SII, calculated as platelet × neutrophil / lymphocyte count, is used as a composite marker of perioperative inflammatory and immune response. The study investigates whether iPACK block with ACB attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.Read full original descriptionShow less

iPACK Block With Adductor Canal Block Mitigates Surgical Stress and Enhances Analgesia in Total Knee Arthroplasty: A Randomized Controlled Trial

This randomized controlled trial evaluates the effect of ultrasound-guided iPACK block with Adductor Canal Block (ACB) on the Systemic Immune-Inflammation Index (SII) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SII, calculated as platelet × neutrophil / lymphocyte count, is used as a composite marker of perioperative inflammatory and immune response. The study investigates whether iPACK block with ACB attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.

Inclusion: Patients with ASA classification I-III; Aged 65-100 years; Who will be scheduled for hip arthroplasty under spinal anesthesia.

Exclusion: Take anticoagulant therapy; Patients who have a history of bleeding diathesis; History of chronic pain before surgery; patients unable to assess their pain (dementia); patients having an infection in the region of the procedure; Multiple trauma; patients operated under general anesthesia; the patient who does not accept the procedure.

ClinicalTrials.gov NCT07449442